Connection

DEBORAH RITTER to Humans

This is a "connection" page, showing publications DEBORAH RITTER has written about Humans.
Connection Strength

0.214
  1. Experiences in providing a community educational resource for the All of Us Researcher Workbench. J Am Med Inform Assoc. 2024 12 01; 31(12):2952-2957.
    View in: PubMed
    Score: 0.024
  2. A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen). Cold Spring Harb Mol Case Stud. 2019 10; 5(5).
    View in: PubMed
    Score: 0.017
  3. Somatic cancer variant curation and harmonization through consensus minimum variant level data. Genome Med. 2016 11 04; 8(1):117.
    View in: PubMed
    Score: 0.014
  4. Identifying gene disruptions in novel balanced de novo constitutional translocations in childhood cancer patients by whole-genome sequencing. Genet Med. 2015 Oct; 17(10):831-5.
    View in: PubMed
    Score: 0.012
  5. Evaluating the consistency of SMARCB1 variant classification and assertions of genotype-phenotype relationships in ClinVar. Cancer Genet. 2025 Sep; 296-297:84-87.
    View in: PubMed
    Score: 0.006
  6. Design and implementation of an action plan for justice, equity, diversity, and inclusion within the Clinical Genome Resource. Am J Hum Genet. 2025 Feb 06; 112(2):215-223.
    View in: PubMed
    Score: 0.006
  7. Large-scale application of ClinGen-InSiGHT APC-specific ACMG/AMP variant classification criteria leads to substantial reduction in VUS. Am J Hum Genet. 2024 Nov 07; 111(11):2427-2443.
    View in: PubMed
    Score: 0.006
  8. Macrocephaly and developmental delay caused by missense variants in RAB5C. Hum Mol Genet. 2023 10 17; 32(21):3063-3077.
    View in: PubMed
    Score: 0.006
  9. Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel. Genet Med. 2024 02; 26(2):100992.
    View in: PubMed
    Score: 0.006
  10. Specifications of the ACMG/AMP Variant Classification Guidelines for Germline DICER1 Variant Curation. Hum Mutat. 2023; 2023.
    View in: PubMed
    Score: 0.005
  11. CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase. Nucleic Acids Res. 2023 01 06; 51(D1):D1230-D1241.
    View in: PubMed
    Score: 0.005
  12. Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is. Database (Oxford). 2023 01 06; 2023.
    View in: PubMed
    Score: 0.005
  13. A community approach to the cancer-variant-interpretation bottleneck. Nat Cancer. 2022 05; 3(5):522-525.
    View in: PubMed
    Score: 0.005
  14. Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions. Cancer Genet. 2022 06; 264-265:50-59.
    View in: PubMed
    Score: 0.005
  15. Evolution of germline TP53 variant classification in children with cancer. Cancer Genet. 2022 06; 264-265:29-32.
    View in: PubMed
    Score: 0.005
  16. Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). Genet Med. 2022 05; 24(5):986-998.
    View in: PubMed
    Score: 0.005
  17. ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines. Genome Med. 2022 01 18; 14(1):6.
    View in: PubMed
    Score: 0.005
  18. Clinical Genetics Lacks Standard Definitions and Protocols for the Collection and Use of Diversity Measures. Am J Hum Genet. 2020 07 02; 107(1):72-82.
    View in: PubMed
    Score: 0.004
  19. Response to Maya et al. Genet Med. 2020 07; 22(7):1278-1279.
    View in: PubMed
    Score: 0.004
  20. A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer. Nat Genet. 2020 04; 52(4):448-457.
    View in: PubMed
    Score: 0.004
  21. Evaluation of the Impact of the Wound Treatment Associate (WTA) Education Program on Practice and Quality Patient Outcomes. J Wound Ostomy Continence Nurs. 2020 Jan/Feb; 47(1):13-19.
    View in: PubMed
    Score: 0.004
  22. Standard operating procedure for curation and clinical interpretation of variants in cancer. Genome Med. 2019 11 29; 11(1):76.
    View in: PubMed
    Score: 0.004
  23. Variant interpretation is a component of clinical practice among genetic counselors in multiple specialties. Genet Med. 2020 04; 22(4):785-792.
    View in: PubMed
    Score: 0.004
  24. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 02; 22(2):245-257.
    View in: PubMed
    Score: 0.004
  25. Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework. Genet Med. 2019 07; 21(7):1507-1516.
    View in: PubMed
    Score: 0.004
  26. Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels. Genet Med. 2019 07; 21(7):1497-1506.
    View in: PubMed
    Score: 0.004
  27. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes. Hum Mutat. 2018 11; 39(11):1542-1552.
    View in: PubMed
    Score: 0.004
  28. Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards. Hum Mutat. 2018 11; 39(11):1721-1732.
    View in: PubMed
    Score: 0.004
  29. The clinical imperative for inclusivity: Race, ethnicity, and ancestry (REA) in genomics. Hum Mutat. 2018 11; 39(11):1713-1720.
    View in: PubMed
    Score: 0.004
  30. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell. 2018 04 05; 173(2):355-370.e14.
    View in: PubMed
    Score: 0.004
  31. ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research. Pac Symp Biocomput. 2018; 23:247-258.
    View in: PubMed
    Score: 0.004
  32. Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study. Cancer. 2017 04 15; 123(8):1464-1474.
    View in: PubMed
    Score: 0.003
  33. Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease. J Clin Invest. 2016 08 01; 126(8):2881-92.
    View in: PubMed
    Score: 0.003
  34. Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs. Pharmacogenet Genomics. 2016 06; 26(6):271-9.
    View in: PubMed
    Score: 0.003
  35. Assessing structural variation in a personal genome-towards a human reference diploid genome. BMC Genomics. 2015 Apr 11; 16:286.
    View in: PubMed
    Score: 0.003
  36. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet. 2013 Oct; 45(10):1226-1231.
    View in: PubMed
    Score: 0.003
  37. cneViewer: a database of conserved non-coding elements for studies of tissue-specific gene regulation. Bioinformatics. 2008 Oct 15; 24(20):2418-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.